U.S. market Closed. Opens in 10 hours

INO | Inovio Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312001-03-312000-03-311999-03-31
Revenue832.01K10.26M1.77M7.41M4.11M30.48M42.22M35.37M40.57M10.46M13.47M4.12M9.80M6.14M9.12M2.10M4.81M3.47M5.47M1.17M80.53K189.52KN/A5.10M5.08M8.30M
Cost of Revenue3.50M5.50M4.73M94.25M88.02MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A1.27M1.46M1.20M
Gross Profit-2.67M4.77M-2.96M-86.83M-83.91M30.48MN/AN/A40.57M10.46M13.47M4.12M9.80M6.14M9.12M2.10M4.81M3.47M5.47M1.17M80.53K189.52KN/A3.83M3.62M7.10M
Operating Expenses132.56M277.84M302.99M131.49M115.22M124.57M126.86M112.60M75.86M49.95M35.01M28.76M32.02M25.36M23.08M15.76M20.71M16.81M17.64M12.68M6.71M6.12MN/A12.17M13.15M14.00M
Selling, General & Admin44.08M90.19M53.75M37.25M27.20M29.32M28.29M23.89M18.06M15.86M13.64M10.78M11.99M12.11M13.67M10.01M11.08M8.08M5.98M6.13M4.57M3.66MN/AN/A5.61MN/A
Research & Development88.48M187.65M249.24M94.25M88.02M95.26M98.57M88.71M57.79M34.10M21.37M17.98M20.03M13.26M9.41M5.75M9.63M8.51M11.45M6.55M2.15M2.47MN/A6.44M6.98M8.10M
Other Operating Expenses-4.71M-3.86M343.37K3.42M496.20K360.80KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A225.00K206.25KN/AN/AN/AN/A5.73M566.36K5.90M
Operating Income-135.23M-267.57M-301.22M-124.08M-111.11M-94.09M-83.64M-77.24M-35.28M-39.50M-21.54M-24.64M-22.23M-19.22M-13.96M-13.66M-15.90M-13.35M-12.17M-11.51M-6.63M-5.93MN/A-8.34M-9.53M-6.90M
Other Expenses / Income109.31K-10.08M-2.01M-38.81M-9.70M-1.63M-4.56M3.50M4.08M3.36M-44.54M4.93M9.28M1.51M-10.50M49.01K3.42MN/A-3.33MN/AN/A26.87KN/A577.68K-597.18K300.00K
Before Tax Income-135.12M-277.65M-303.22M-162.89M-120.81M-94.80M-88.21M-73.74M-31.20M-36.14M-66.08M-19.71MN/AN/AN/AN/AN/AN/AN/AN/AN/A-5.91MN/AN/AN/AN/A
Income Tax Expenses2.0010.01M2.16M52.20M-257.33K2.17MN/AN/A-2.10MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-135.12M-287.66M-305.38M-215.09M-120.55M-96.97M-88.21M-73.74M-29.19M-36.12M-66.03M-19.67M-15.25M-17.61M-24.41M-12.97M-11.20M-12.48M-15.30M-10.97M-4.66M-5.96MN/A-8.64M-9.60M-6.60M
Interest Expenses1.22M1.25M1.94M8.70M7.95M346.09KN/AN/AN/AN/AN/AN/A34.28KN/AN/AN/AN/AN/AN/AN/A20.48K5.45KN/A20.38K24.34KN/A
Basic Shares Outstanding22.17M19.89M17.40M12.93M8.23M92.54M81.78M73.21M68.20M59.13M46.09M34.13M31.56M25.80M18.68M10.98M10.37M7.88M4.75M4.41M3.33M2.54M1.73M1.73M1.38M1.25M
Diluted Shares Outstanding22.17M19.89M17.40M12.93M8.23M92.54M81.92M73.21M68.37M59.41M46.09M34.13M31.56M25.80M18.68M10.98M10.37M7.88M4.75M4.41M3.33M2.54M1.73M1.73M1.41M1.25M
EBITDA-131.72M-268.55M-293.33M-76.17M-105.58M-89.46M-84.74M-70.65M-29.37M-34.55M-63.93M-17.67M-13.21M-15.51M-22.73M-11.97M-10.25M-11.57M-14.50M-10.40M-4.06M-5.34MN/A-7.96M-9.01M-6.20M
EBITDA Margin-15,831.92%-2,616.89%-16,528.13%-1,027.76%-2,567.66%-293.47%-200.70%-199.77%-72.38%-330.43%-474.70%-429.12%-134.83%-252.34%-249.28%-570.77%-213.19%-333.53%-265.17%-891.09%-5,041.68%-2,817.65%0.00%-156.26%-177.44%-74.70%
EBIT-133.89M-276.40M-301.29M-154.19M-112.86M-94.45M-88.21M-73.74M-31.29M-36.12M-66.03M-19.67M-15.22M-17.61M-24.41M-12.97M-11.20M-12.48M-15.30M-10.97M-4.64M-5.96MN/A-8.62M-9.58M-6.60M
EBIT Margin-16,092.90%-2,693.35%-16,976.28%-2,080.47%-2,744.71%-309.86%-208.92%-208.49%-77.11%-345.44%-490.29%-477.56%-155.37%-286.65%-267.67%-618.11%-233.05%-359.82%-279.79%-940.19%-5,767.40%-3,144.44%0.00%-169.12%-188.59%-79.52%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312001-03-312000-03-311999-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙